Drug

Corabotase

Corabotase: highest development phase Phase 3, developed by Ipsen. 4 trial records tracked on RxWires.

Trials

Drug	Phase	Indication
Corabotase NCT07435428	Phase 3	Moderate to Severe Glabellar Lines
Corabotase NCT06625060	Phase 2	Episodic Migraine
Corabotase NCT04821089	Phase 1/2	Moderate to Severe Upper Facial Lines
Corabotase NCT04752774	Phase 1/2	Spasticity

Follow Corabotase on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.

Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.